| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1007080715 |
| P356 | DOI | 10.1007/S00393-011-0923-2 |
| P698 | PubMed publication ID | 23202996 |
| P50 | author | Stefan Kleinert | Q80260007 |
| P2093 | author name string | K Krueger | |
| S Störk | |||
| P2860 | cites work | Statins for the primary prevention of cardiovascular disease | Q24234813 |
| Atherosclerosis — An Inflammatory Disease | Q26776972 | ||
| Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein | Q29547752 | ||
| EULAR evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other forms of inflammatory arthritis | Q33505914 | ||
| Inflammation in atherosclerosis: from pathophysiology to practice | Q33709505 | ||
| Autoantibodies and the risk of cardiovascular events | Q33721605 | ||
| The immune system in atherosclerosis | Q34164644 | ||
| ESC/EAS Guidelines for the management of dyslipidaemias: the Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS). | Q34196167 | ||
| C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease | Q34311841 | ||
| C-reactive protein and reclassification of cardiovascular risk in the Framingham Heart Study | Q34552689 | ||
| 34th Bethesda Conference: Task force #1--Identification of coronary heart disease risk: is there a detection gap? | Q35150514 | ||
| Systematic review and meta-analysis of methotrexate use and risk of cardiovascular disease | Q35377706 | ||
| Longitudinal predictors of progression of carotid atherosclerosis in rheumatoid arthritis | Q35489690 | ||
| Disease-modifying antirheumatic drugs are associated with a reduced risk for cardiovascular disease in patients with rheumatoid arthritis: a case control study | Q35605663 | ||
| Cardiovascular events in early RA are a result of inflammatory burden and traditional risk factors: a five year prospective study | Q35617716 | ||
| The influence of rheumatoid arthritis disease characteristics on heart failure. | Q35915244 | ||
| Reduction in the incidence of myocardial infarction in patients with rheumatoid arthritis who respond to anti-tumor necrosis factor alpha therapy: results from the British Society for Rheumatology Biologics Register | Q36732112 | ||
| Cardiovascular disease in patients with rheumatoid arthritis: results from the QUEST-RA study | Q36757060 | ||
| The use of high-sensitivity assays for C-reactive protein in clinical practice | Q37090943 | ||
| Obesity and cardiovascular disease: risk factor, paradox, and impact of weight loss | Q37491629 | ||
| Systematic review and meta‐analysis: Anti–tumor necrosis factor α therapy and cardiovascular events in rheumatoid arthritis | Q37801353 | ||
| Clinical utility of inflammatory markers and advanced lipoprotein testing: advice from an expert panel of lipid specialists. | Q37943475 | ||
| The risk of myocardial infarction and pharmacologic and nonpharmacologic myocardial infarction predictors in rheumatoid arthritis: a cohort and nested case-control analysis | Q40053146 | ||
| Statin use in rheumatoid arthritis in relation to actual cardiovascular risk: evidence for substantial undertreatment of lipid-associated cardiovascular risk? | Q43255462 | ||
| Treatment with tumor necrosis factor inhibitors and the risk of acute coronary syndromes in early rheumatoid arthritis | Q44293608 | ||
| Association between anti-cyclic citrullinated peptide antibodies and ischemic heart disease in patients with rheumatoid arthritis | Q44453472 | ||
| Heart disease and stroke statistics--2006 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee | Q45002081 | ||
| Cardiovascular outcomes in male veterans with rheumatoid arthritis. | Q45331961 | ||
| Rapid increase in myocardial infarction risk following diagnosis of rheumatoid arthritis amongst patients diagnosed between 1995 and 2006. | Q45781042 | ||
| Prevalence of conventional risk factors in patients with coronary heart disease | Q47677468 | ||
| Tumour necrosis factor antagonist use and associated risk reduction of cardiovascular events among patients with rheumatoid arthritis. | Q53725487 | ||
| 2010 ACCF/AHA Guideline for Assessment of Cardiovascular Risk in Asymptomatic Adults: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines | Q57072727 | ||
| Baseline levels of c-reactive protein and prediction of death from cardiovascular disease in patients with inflammatory polyarthritis : A ten-year followup study of a primary care-based inception cohort | Q57804967 | ||
| Antirheumatic drug use and the risk of acute myocardial infarction | Q80016233 | ||
| Treatment with tumor necrosis factor blockers is associated with a lower incidence of first cardiovascular events in patients with rheumatoid arthritis | Q81922641 | ||
| Effectiveness of statins on total cholesterol and cardiovascular disease and all-cause mortality in osteoarthritis and rheumatoid arthritis | Q82299864 | ||
| Remission is the goal for cardiovascular risk management in patients with rheumatoid arthritis: a cross-sectional comparative study | Q83355833 | ||
| The recognition and assessment of cardiovascular risk in people with rheumatoid arthritis in primary care: a questionnaire-based study of general practitioners | Q84207842 | ||
| [Cardiovascular comorbidity and its risk factors in rheumatoid arthritis] | Q84815164 | ||
| P433 | issue | 10 | |
| P921 | main subject | rheumatoid arthritis | Q187255 |
| P1104 | number of pages | 9 | |
| P304 | page(s) | 850-858 | |
| P577 | publication date | 2012-12-01 | |
| P1433 | published in | Zeitschrift fuer Rheumatologie | Q15763293 |
| P1476 | title | [Risk of atherosclerosis mediated by inflammation in rheumatoid arthritis] | |
| P478 | volume | 71 |
Search more.